Author

Thomas P. Brady

Cidara Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alain NoncovichiD· 1 shared Allen Borchardt· 1 shared Amanda L. Almaguer· 1 shared Daniel C. Bensen· 1 shared Douglas E. Zuill· 1 shared Elizabeth Abelovski· 1 shared Grayson HoughiD· 1 shared James M Levin· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alain NoncovichORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CD388: A universally protective Drug-Fc Conjugate that targets influenza virus neuraminidase

Simon Döhrmann, James M Levin, Jason N. Cole, Allen Borchardt, Karin Amundson, Amanda L. Almaguer, Elizabeth Abelovski, Rajvir Grewal, Douglas E. Zuill, Nicholas Dedeic, Grayson Hough, Joanne Fortier, Joanna L. Donatelli, Thanh Lam, Zhiyong Chen, , Leslie W. Tari

This paper describes CD388, a drug-Fc conjugate that targets influenza virus neuraminidase, showing universal antiviral activity across multiple strains and demonstrating efficacy in mouse models.

Nature Microbiology · Mar 17, 2025Peer-reviewedMicrobiology